← Eichor
Condition: Healthy Adult Participants Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Healthy Adult Participants

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Health
Phase 1 · 1 location(s) · Shenzhen Kexing Pharmaceutical Co., Ltd. · NCT07237464A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Parti
Phase 2 · 8 location(s) · ModernaTX, Inc. · NCT07561294A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled R
Phase 1 · 1 location(s) · Revagenix, Inc. · NCT07709494A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administratio
Phase 1 · 3 location(s) · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07204418A Study of V118E in Healthy Participants (V118E-003)
Phase 1 · 4 location(s) · Merck Sharp & Dohme LLC · NCT07168915Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult Participants
Phase 1 · 2 location(s) · Shionogi · NCT07093580FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Phase 1 · 5 location(s) · Pfizer · NCT06564389First-in-Human Study of VNT-101: Safety, Tolerability, and Pharmacokinetics
Phase 1 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07169318A Phase I Study of SSGJ-716 in Healthy Adults and Participants With Moderate-to-Severe Atopic Dermatitis
Phase 1 · 1 location(s) · Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. · NCT07693738A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body of Hea
Phase 1 · 1 location(s) · Pfizer · NCT06994897Study of ABS-201 Evaluating Single and Multiple Ascending Doses in Healthy Adults With and Without Androgenetic Alopecia
Phase 1/Phase 2 · 4 location(s) · Absci Pty Ltd. · NCT07317544A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous A
Phase 1 · 1 location(s) · Incyte Corporation · NCT07448155A Study to Assess the Adverse Events and How Bretisilocin Intramuscular Injection Moves Through the Body of Healthy Adul
Phase 1 · 1 location(s) · AbbVie · NCT07604558Gait Analysis Parameter and Upper Limb Evaluation in Control Participants
NA · 1 location(s) · Centre Hospitalier Universitaire de Liege · NCT07136506A First-in-Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of Debio
Phase 1 · 1 location(s) · Debiopharm International SA · NCT07035769Kimchi and Gut Health
NA · 2 location(s) · University of California, Davis · NCT07435831Phase I Study of CPD704 Inhalation Suspension in Healthy Subjects
Phase 1 · 1 location(s) · Beijing Tide Pharmaceutical Co., Ltd · NCT07301203A Study to Evaluate How Multiple Doses of Itraconazole Interacts With Nacresertib in Healthy Adult Participants
Phase 1 · 1 location(s) · AbbVie · NCT07649954To Test a New Drug (LCFA-01) for Safety and PK in Healthy Adults for Bacterial Vaginosis Infection.
Phase 1 · 1 location(s) · Massachusetts General Hospital · NCT07514416Oil Pulling Whitening Mouthwash
NA · 1 location(s) · The University of Texas Health Science Center at San Antonio · NCT07667088A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity
Phase 1 · 2 location(s) · Hoffmann-La Roche · NCT07499050A Study to Assess the Safety of ARGX-124 in Healthy Volunteers
Phase 1 · 1 location(s) · argenx · NCT07377396A Study to Investigate the Relative Bioavailability and Food Effect of Tablet for Oral Suspension of Sonrotoclax in Heal
Phase 1 · 1 location(s) · BeOne Medicines · NCT07628881Safety, Tolerability, and Pharmacokinetic Evaluation of ADB116 for Injection
Phase 1 · 1 location(s) · Jiangsu Aidea Pharmaceutical Group Co., Ltd. · NCT07729839A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Particip
Phase 1 · 6 location(s) · AstraZeneca · NCT06980428Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers A
Phase 1 · 1 location(s) · Innovent Biologics (Suzhou) Co. Ltd. · NCT07554222Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants
Phase 1 · 1 location(s) · Newsoara Biopharma Co., Ltd. · NCT07281703Evaluation of [18F]GATT-44 for Positron Emission Tomography Imaging of the GABA Transporter-1
EARLY_Phase 1 · 1 location(s) · Yale University · NCT07457736A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
Phase 1 · 1 location(s) · Merck Sharp & Dohme LLC · NCT07300280A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants
Phase 1 · 1 location(s) · AbbVie · NCT07599761
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.